CYP1A2 polymorphism (C > a at position -163) in Ovambos, Koreans and Mongolians

Cell Biochemistry and Function

Volumn 25, Issue 5, 2007, Pages 491-494

  Fujihara, Junko ^a   Shiwaku, Kuninori ^a   Xue, Yuing ^a   Kataoka, Kaori ^a   Hieda, Yoko ^a   Takeshita, Haruo ^a  

^a SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

Author keywords

CYP1A2; Koreans; Mongolians; Ovambos; Polymorphism

Indexed keywords

CYTOCHROME P450 1A2;

ALLELE; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; GENE FREQUENCY; GENE MUTATION; HUMAN; KOREA; MAJOR CLINICAL STUDY; MONGOLIA; MORBIDITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADENINE; AFRICAN CONTINENTAL ANCESTRY GROUP; ASIAN CONTINENTAL ANCESTRY GROUP; CYTOCHROME P-450 CYP1A2; CYTOSINE; GENE FREQUENCY; GENOTYPE; HUMANS; KOREA; MONGOLIA; MUTATION; NAMIBIA; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 34548755526     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.1336     Document Type: Article

References (22)

1. Sofowora GG, Choo FE, Mayo G, Shyr Y, Wilkinson RG. In vivo inhibition of human CYP1A2 activity by oltipraz. Cancer Chemother Pharmacol 2001; 47: 505-510.
2. Cusack JB, Dawson WG, Mercer DG, Vestal ER. Cigarette smoking and theophylline metabolism: effects of cimetidine. Clin Pharmacol Ther 1985; 37: 330-336.
3. Kalow W, Tang KB. Caffeine as a metabolic probe: exploration of the enzyme-inducing effect of cigarette smoking. Clin Pharmacol Ther 1991; 49: 44-48.
4. Quattrochi CL, Vu T, Turkey HR. The human CYP1A2 gene and induction by 3-methylcholanthrene. A region of DNA that supports AH-receptor binding and promoter-specific induction. J Biol Chem 1994; 269: 6949-6954.
5. Corchero J, Pimprale S, Kimura S, Gonzalez JF. Organization of the CYP1A cluster on human chromosome 15: implications for gene regulation. Pharmacogenetics 2001; 11: 1-6.
6. Oscarson M. Pharmacogenetics of drug metabolising enzymes: importance for personalized medicine. Clin Chem Lab Med 2003; 41: 573-580.
7. Nakajima M, Yokoi T, Mizutani M, Kinoshita M, Funayama M, Kamataki T. Genetic polymorphism in the 5′-flanking region in humans. J Biochem 1999; 125: 803-808.
8. Sachse C, Brockmoller J, Bauer S, Roots I. Functional significance of a C → A polymorphism in intron 1 of the cytochrome P450CYP1A2 gene tested with caffeine. Br J Clin Pharmacol 1999; 47: 445-449.
9. Cornells CM, Sohemy AE, Campos H. Genetic polymorphism of CYP1A2 increases the risk of myocardial infarction. J Med Genet 2004; 41: 758-762.
10. Torres FC, Cantu AM, Leon MB, et al. CYP1A2 phenotype and genotype in a population from the carboniferous region of Coahuila, Mexico. Toxicol Lett 2005; 156: 331-339.
11. Sachse C, Bhambra U, Smith G, et al. Polymorphisms in the cytochrome P450 CYP1A2 gene (CYP1A2) in colorectal cancer patients and controls: allele frequencies, linkage disequilibrium and influence on caffeine metabolism. Br J Clin Pharmacol 2003; 55: 68-76.
12. Todesco L, Török M, Krähenbühl S, Wenk M. Determination of -3858G → A and -164C → A genetic polymorphisms of CYP1A2 in blood and saliva by rapid allelic discrimination: large difference in the prevalence of the -3858G → A mutation between Caucasians and Asians. Eur J Pharmacol 2003; 59: 343-346.
13. Hamdy SI, Hiratsuka M, Narahara K, et al. Genotyping of four genetic polymorphisms in the CYP1A2 gene in the Egyptian population. Br J Clin Pharmacol 2003; 55: 321-324.
14. Aklillu E, Carrillo JA, Makonnen E, et al. Genetic polymorphism of CYP1A2 in Ethiopians affecting induction and expression: characterization of novel haplotypes with single-nucleotide polymorphisms in intron 1. Mol Pharmacol 2003; 64: 659-669.
15. Dandara C, Basvi PT, Bapiro ET, Sayi J, Hasler JA. Frequency of -163C > A and 63 C > G single nucleotide polymorphism of cytochrome P450 1A2 in two African populations. Clin Chem Lab Med 2004; 42: 939-941.
16. Han XM, Ou-Yang DS, Lu PX, et al. Plasma caffeine metabolite ratio (17X/137X) in vivo associated with G-2964A and C734A polymorphisms of human CYP1A2. Pharmacogenetics 2001; 11: 429-435.
17. Soyama A, Saito Y, Hanioka N, et al. Single nucleotide polymorphisms and haplotypes of CYP1A2 in a Japanese population. Drug Metab Pharmacokinet 2005; 20: 24-33.
18. Takeshita H, Yasuda T, Nakajima T, et al. Detection of the two short tandem repeat loci (HumTPO and HumLPL) in Japanese populations using discontinuous polyacrylamide gel electrophoresis. Nippon Houigaku Zasshi 1998; 52: 139-143.
19. Katoh T, Mano S, Munkhbat B, et al. Genetic features of Khoton Mongolians revealed by SNP analysis of the X chromosome. Gene 2005; 357: 95-102.
20. Machulla HKG, Batnasan D, Steinborn F, et al. Genetic affinities among Mongol ethnic groups and their relationship to Turks. Tissue Antigens 2003; 61: 292-299.
21. Yasuda T, Kawai Y, Ueki M, Kishi K. Clinical applications of DNase I, a genetic marker already used for forensic identification. Leg Med 2005; 7: 274-277.
22. Fujihara J, Hieda Y, Takeshita H, et al. Analysis of genetic polymorphism of deoxyribonuclease I (DNase I) in Ovambo and Turk populations using genotyping method. Biochem Genet 2005; 43: 631-638.